Prescription Pathways from Initial Medication Use to Triple Therapy in Oder Individuals with COPD: A Real-World Population Study

被引：0
|
作者：
Gershon, A. S. [1 ]
Jiang, L. [2 ]
Tan, W-C [3 ]
Kendzerska, T. [4 ]
Stukel, T. [5 ]
Aaron, S. D. [6 ]
Pequeno, P. [5 ]
Stanbrook, M. B. [7 ]
机构：
[1] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Toronto, ON, Canada
[3] St Paulshosp Univ BC, Vancouver, BC, Canada
[4] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] ICES, Toronto, ON, Canada
[6] Ottawa Hosp, Ottawa, ON, Canada
[7] Toronto Western Hosp, Toronto, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1638
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy
    Valentina Perrone
    Chiara Veronesi
    Marco Gambera
    Giulio Nati
    Francesco Perone
    Paola Fausta Tagliabue
    Luca Degli Esposti
    Massimo Volpe
    High Blood Pressure & Cardiovascular Prevention, 2019, 26 : 399 - 404
  • [32] Predictors of Comparative Real-World Effectiveness of Triple Therapy Versus Dual Bronchodilation in Frequently Exacerbating Patients with COPD
    Kerkhof, M.
    Voorham, J.
    Georges, G.
    Vezzoli, S.
    Papi, A.
    Vogelmeier, C.
    Singh, D.
    Fabbri, L. M.
    Kocks, J. W. H.
    Price, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [33] Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1975 - 1986
  • [34] TriOptimize IX: Real-world improvement in COPD symptoms and lung function by extrafine singleinhaler triple therapy (efSITT)
    Trinkmann, F.
    Javan, S. Bahari
    Criee, C.
    Bogoevska, V
    Gessner, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] A real-world study about exacerbations and medical cost of COPD according to inhaler use
    Lee, Kyu Jin
    Hwang, Yonge Il
    Lee, Myung Goo
    Jang, Seun Hun
    Park, Yong Bum
    Yoo, Kwang Ha
    Jung, Ki-Suck
    RESPIROLOGY, 2023, 28 : 268 - 268
  • [36] A Real-world Study Evaluating the Clinical Factors Associated with the Initial SGLT2 Inhibitor Prescription
    Chu, Michelle
    Lou, Mimi
    Wang, Mengxi
    Flores, Allison
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2024, 35 (03)
  • [37] Extrafine Single Inhaler Triple Therapy Reduces Use Of Rescue Medication In COPD Patients: Results From The Trinity Study
    Scuri, M.
    Singh, D.
    Papi, A.
    Corradi, M.
    Montagna, I.
    Francisco, C.
    Cohuet, G.
    Vezzoli, S.
    Muraro, A.
    Petruzzelli, S.
    Vestbo, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [38] TRICOP - A real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 616 - 616
  • [39] TRICOP - A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD
    Marth, Katharina
    Renner, Andreas
    Pohl, Wolfgang
    RESPIRATORY MEDICINE, 2021, 182
  • [40] Characteristics of exacerbating COPD patients with productive cough and on inhaled triple therapy, by smoking status: a real-world multi-country study
    Janssens, Wim
    Nordon, Clementine
    Coak, Emily
    Pennant, Tia
    Bell, George
    Mullerova, Hana
    Draffan, Lynda
    Alves, Joao Andre
    Fageras, Malin
    De Soyza, Anthony
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345